Heart Test Laboratories Inc
For the period ended Jan 31, 2024. Filed Mar 14, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jan 31, 2024 · Filed Mar 14, 2024
HSCS$2.71-4.2%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 1. Condensed Unaudited Financial Statements
| Condensed Balance Sheets as of January 31, 2024 and April 30, 2023 | 1 | |
| Condensed Statements of Operations for the three and nine months ended January 31, 2024 and 2023 | 2 | |
| Condensed Statements of Stockholders' Equity (Deficit) for the three months ended January 31, 2024 and 2023 | 3 | |
| Condensed Statements of Stockholders' Equity (Deficit) for the nine months ended January 31, 2024 and 2023 | 4 | |
| Condensed Statements of Cash Flows for the nine months ended January 31, 2024 and 2023 | 5 | |
| Notes to the Condensed Unaudited Financial Statements | 6 | |
| Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 20 |
|---|---|---|
| Item 3. | Quantitative and Qualitative Disclosures About Market Risk | 26 |
| Item 4. | Controls and Procedures | 26 |
| PART II. | OTHER INFORMATION | 28 |
| Item 1. | Legal Proceedings | 28 |
| Item 1A. | Risk Factors | 28 |
| Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 28 |
| Item 3. | Defaults Upon Senior Securities | 28 |
| Item 4. | Mine Safety Disclosures | 28 |
| Item 5. | Other Information | 28 |
| Item 6. | Exhibits | 29 |
| Signatures | 33 |
i
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.